Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024
Cash flows from operating activities:
Net loss	$ (4,191)	$ (6,613)
Adjustments to reconcile net loss to net cash from operating activities:
Depreciation and amortization	1,248	1,412
Amortization of core deposit intangible	20	3
Amortization and accretion of premiums and discounts on investments, net	(25)	611
Accretion of deferred loan fees and purchased premiums, net	(1,784)	(1,535)
Amortization of debt issuance costs	72	78
Change in fair value of sold loan servicing rights	280	550
Additions to servicing rights on sold loans, net	(13)	(38)
Provision for credit losses on loans	7,320	16,716
Recapture of provision for credit losses on unfunded commitments	(5)	(218)
Deferred Income Tax Expense (Benefit)	(2,014)	(1,409)
Allocation of ESOP shares	485	622
Share-based compensation expense	733	957
Gain on sale of loans, net	(112)	(312)
Loss on sale of securities available for sale, net	0	2,117
Gain on extinguishment of subordinated debt	(848)	0
Increase in cash surrender value of life insurance, net	(1,889)	(1,179)
Income from death benefit on bank-owned life insurance, net	(1,059)	(1,536)
Origination of loans held for sale	(25,166)	(22,197)
Proceeds from loans held for sale	31,168	22,790
Legal settlement paid	(5,740)	0
Insurance reimbursement	1,681	0
Change in assets and liabilities:
Decrease (increase) in accrued interest receivable	1,661	(265)
Decrease (increase) in ROU asset	1,405	(10,954)
Decrease in prepaid expenses and other assets	476	2,380
Decrease in accrued interest payable	(2,072)	(101)
(Decrease) increase in lease liabilities	(1,096)	11,107
(Decrease) increase in accrued expenses and other liabilities	(3,293)	3,890
Net cash (used) provided by operating activities	(2,758)	16,876
Cash flows from investing activities:
Purchase of securities available for sale	(5,534)	(99,963)
Proceeds from maturities, calls, and principal repayments of securities available for sale	85,976	33,874
Proceeds from sales of securities available for sale	0	21,048
Redemption (purchase) of FHLB stock	1,330	(771)
Early surrender of bank-owned life insurance policy	9,375	14,616
Purchase of bank-owned life insurance	(9,109)	(14,616)
Proceeds from bank-owned life insurance death benefit	1,968	1,602
Net decrease (increase) in loans receivable	49,762	(47,849)
Proceeds from sale of premises and equipment	417	6,508
Capital contributions to partnership investments	(990)	(6,502)
Redemption of partnership investment	0	5,931
Capital disbursements from partnership agreements	794	1,067
Capital contributions to low-income housing tax credit partnerships	(1,051)	(2,011)
Net cash provided (used) by investing activities	132,938	(87,066)
Cash flows from financing activities:
Net (decrease) increase in deposits	(88,925)	11,134
Proceeds from long-term FHLB advances	30,000	105,000
Repayment of long-term FHLB advances	(30,000)	(25,000)
Net decrease in short-term FHLB advances	(30,000)	(65,000)
Redemption of subordinated debt, net	(4,095)	0
Net increase in line of credit	7,000	0
Net (decrease) increase in advances from borrowers for taxes and insurance	(60)	224
Payment of dividends	(1,318)	(2,645)
Restricted stock awards canceled	(113)	(187)
Repurchase of common stock	0	(4,057)
Net cash (used) provided by financing activities	(117,511)	19,469
Net increase (decrease) in cash and cash equivalents	12,669	(50,721)
Cash and cash equivalents at beginning of year	72,448	123,169
Cash and cash equivalents at end of year	85,117	72,448
Supplemental disclosures of cash flow information:
Cash paid for interest on deposits and borrowings	51,832	56,121
Cash paid for income taxes	12	83
Supplemental disclosures of noncash investing activities:
Change in unrealized loss on securities available for sale	10,382	2,406
Change in unrealized (loss) gain on fair value hedge	(760)	834
Change in unrealized gain (loss) on DB Plan	126	(252)
Amortization of unrecognized DB plan prior service cost	150	150
Loan principal transferred from held-for-investment to held-for-sale	6,480	0
Loan principal transferred to real estate owned and repossessed assets, net	1,380	0
Lease liabilities arising from obtaining right-of-use assets	1,264	12,158
Series A equity investment acquired upon conversion of commercial business loan	1,260	0
Write-down of equity investment	$ 0	$ (1,762)